TCBP News and Press, TC BioPharm (Holdings) plc

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia PR Newswire 5 patients treated in "safety cohort" showed no drug related Serious Adverse Events Restart of trial after amendment approved by MHRA to increase dose level ...

2024-06-06 16:42:34 ET More on TC Biopharm TC Biopharm executes second LOI to buy CAR-T therapies, shares up TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics Financial information for TC Biopharm Read the full articl...

TCBP Announces Launch of Compassionate Use Program for TCB008 PR Newswire The Company's lead therapeutic will be available through a newly opened compassionate use program EDINBURGH, Scotland , May 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ...

2024-05-07 10:01:47 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

2024-05-07 06:02:00 ET 3 Tips for Buying and Selling Penny Stocks During After Hours Trading penny stocks during after-hours sessions offers unique opportunities for investors seeking to capitalize on market movements outside of standard trading hours. Penny stocks , typically price...

TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds PR Newswire EDINBURGH, Scotland , May 6, 2024 /PRNewswire/ -- TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company develo...

2024-05-06 10:01:41 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

A look at the top 10 most actives in the United States XBP Europe Holdings Inc. (XBP) rose 69.1% to $3.5846 on volume of 37,660,870 shares Lyra Therapeutics Inc. (LYRA) fell 90.2% to $0.3942 on volume of 21,985,500 shares NIO Inc. American depositary shares each representing one Class A (...

2024-05-06 09:17:28 ET More on TC Biopharm TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics TCBP announces exercise of series D warrants for cash Financial information for TC Biopharm Read the full article on Seeking...

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies PR Newswire Acquisition target has established proof of concept data demonstrating the therapeutic potential for the treatment of multiple solid tum...